Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Psychiatry/Psychology | Neurology | Genetic Disease | Family Medicine
Disease Category: Bipolar Disorder
Location: United States, TX
A Randomized, Double-Bllind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects with BiPolar I Disorder
Individuals 18 and older with Type I Bipolar Disorder. Qualified participants receive study related care and study medication at no charge. Participants may receive compensation for time and travel up to $1120.00.
Patient Inclusion Criteria:
- Bipolar Type I
- Depressed, Mixed or Manic
- May be currently treated with Lithium or Depakote
Patient Exclusion Criteria:
- Cancer within past 5 years
- Active seizure disorder
- Active Hepatitis
- Alcohol or substance abuse or dependence within 12 months
- Type I Diabetes
- Insulin Dependent Diabetics
- Participated in a study within 6 months
R/D Clinical Research, Inc.
461 This Way
Lake Jackson, TX 77566
Research Center Information: R/D Clinical Research, Inc.
If you would like to learn more about participating in this study, please send an email message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these